SCHEMBL7357435

SCHEMBL7357435

CC(O[C]=O)C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 2/20 0.48
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
HCAR2 Q8TDS4 1/20 0.44
ATM Q13315 1/20 0.43
CTSS P25774 4/20 0.43
CTSB P07858 3/20 0.43
CTSL P07711 3/20 0.43
CTSK P43235 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20435071 0.81 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL16673135 0.81 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL14408397 0.81 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL20091143 0.81 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL8847568 0.80 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL6960308 0.79 ALDH1A1 (0.56) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL7429091 0.79 ALDH1A1 (0.60) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL10493728 0.79 ALDH1A1 (0.60) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL6133452 0.79 SRR (0.47) ALDH1A1L3MBTL1LMNATDP1MAPK1
SCHEMBL212215 0.79 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829191-B2 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof FOREST RESEARCH INC 2014-09-09 US claimed
US-8003117-B2 Purity; polyether containing glycerol backbone capable of being label NOF CORPORATION (JP) 2011-08-23 US disclosed
EP-1114024-B1 UROKINASE INHIBITORS PENTAPHARM AG (CH) 2002-11-27 EP disclosed
WO-2002017925-A1 NON-SYMMETRIC TRIPYRRANNES IN THE SYNTHESIS OF NOVEL MACROCYCLES PHARMACYCLICS, INC. (US) 2002-03-07 WO disclosed
US-5866592-A Fibrinogen receptor antagonist and pharmaceutical compositions comprising the same NIPPON STEEL CORPORATION (JP) 1999-02-02 US disclosed
EP-0800516-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1997-10-15 EP disclosed
WO-1996020172-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1996-07-04 WO disclosed
US-5037733-A High speed, storage stable photographic films and papers, surface bromination of silver halide grains, cyanine dyes FUJI PHOTO FILM CO., LTD. (JP) 1991-08-06 US disclosed
EP-0001265-A1 O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds MERCK & CO. INC. (US) 1979-04-04 EP disclosed